ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SHP Shire

4,690.00
0.00 (0.00%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Shire LSE:SHP London Ordinary Share JE00B2QKY057 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 4,690.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Shire Share Discussion Threads

Showing 3401 to 3421 of 5350 messages
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older
DateSubjectAuthorDiscuss
28/3/2018
11:35
Happy holding, just arrived in South of France, welcome gift, the action has only just started!
ny boy
28/3/2018
11:30
Bid would have to beat the Abvie offer surely
mbmiah
28/3/2018
11:20
Just remembering how stressful (and exciting) the AbbVie bid situation was. Will be interesting to experience that all over again if a bid is made. Glad Susan Kilby is still chair - she was instrumental in exacting a good price and terms from AbbVie including the break clause.
romeike
28/3/2018
11:16
We all know this worth 50+.

If the bid comes, that's where we're headed.

ruethewhirl
28/3/2018
11:14
You think shire was volatile before?

Next wee while will be a rollercoaster.

Bids, retractions, rumour mill in high gear, speculators piling in.

ruethewhirl
28/3/2018
11:12
At the very least it will bring some welcome focus on to the fundamentals at Shire and the strong performance rather than the obsessive negative narrative around a potential neuroscience spin off.

It is encouraging that in Takeda statements it shows interest in both aspects of the Shore business, neuro, to complement their existing operation and also the rare diseases.

romeike
28/3/2018
11:04
might encourage some others to consider a bid ...
mister md
28/3/2018
11:01
Any offer would have to be at a very serious premium to the current share price. I would say £52 - £58. Certainly would be annoyed to see them agree to anything less than £52 as I think Shire could get back to that level on their own with no need for a deal.
romeike
28/3/2018
10:58
Dooes Takeda have the chedder for this scale of takeover? stories last year saying their planned purchases would be in the $15-$20bn mark this is far larger especially after their spends this year already. on the otherhand thrilled to be back in profit of this fella
hortensius
28/3/2018
10:42
Small in/out for me.


Congrats guys, realise some of you are holding in quantity, well done for
keeping the faith, that was not easy to do.

essentialinvestor
28/3/2018
10:41
My Shire holding just exploded back into profit, been a shareholder for over a decade. If there is an offer I hope it is a sensible £50+.
romeike
28/3/2018
10:41
Yep considering an approach. Preliminary and exploratory sage. No approach has been made to the board and no certainty they will so I think that is keeping a lid on the rise. Hopefully smokes out other bidders.
billytkid2
28/3/2018
10:41
Japan’s Takeda Pharmaceutical said on Wednesday that it is “considering making an approach” to buy Shire, the Irish drugmaker.

Takeda said its consideration is still “at a preliminary and exploratory stage and no approach has been made to the board of Shire.”

kamitora
28/3/2018
10:40
Well done to all that stayed with Shire, you all deserve that good luck :o)
jpjohn1
28/3/2018
10:39
Where is nyboy?

Got in around 3000.

Great call...!!!

ruethewhirl
28/3/2018
10:38
Takada. No further info at present.

Congratulations to us, the true believers.

Knew that there was value here.

ruethewhirl
28/3/2018
10:37
from CNBC Takeda confirming approach
dechy
28/3/2018
10:25
shire in play !!!
alchemy30
28/3/2018
10:20
Billy, thanks for that. I'm tempted to buy back a few.
essentialinvestor
28/3/2018
10:17
Apparently the stock is up as Shire could be a beneficiary from worries about the safety of Roches Hemlibra. The Hemopjilia Federation have highlighted the deaths of 5 patients on that drug. Some other companies dealing in that space are also up.
billytkid2
28/3/2018
10:11
Could be folks are quitting tech for something more defensive. Seems inevitable there will be a steep correction over in the US for certain stocks that have climbed to ridiculous levels.
romeike
Chat Pages: Latest  142  141  140  139  138  137  136  135  134  133  132  131  Older

Your Recent History

Delayed Upgrade Clock